BioSpace News Archive

BioMidwest

Express Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program

- In its first year, the Express Scripts Diabetes Care Value program delivered nearly $43 million savings for plans; reduced heart attack risk in 15 percent of patients

October 3, 2018
·
4 min read
Policy

Marapharm Ventures Inc. Announces Health Canada ACMPR Application Update

Marapharm Ventures Inc. is very pleased to announce, the Company has submitted the necessary amendments to its late-stage, Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application.

October 3, 2018
·
8 min read
Policy

VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain

Designation highlights serious unmet need for new treatment options for patients suffering from neuropathic pain

October 3, 2018
·
6 min read
Business

Priority Health First to Offer Omada Health Virtual Diabetes Prevention Tool to Michigan

Priority Health will provide clinically-eligible members access to Omada, the country’s leading digital Diabetes Prevention Program (DPP), beginning this month.

October 3, 2018
·
4 min read
Biotech Beach

MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes

MannKind Corporation (Nasdaq:MNKD), announced that it presented new scientific data in an oral and poster presentation at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Berlin, Germany.

October 3, 2018
·
5 min read
Business

Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products

Emerald Health Therapeutics, Inc. has entered into a research agreement with VivaCell Biotechnologies Spain S.L.U.

October 3, 2018
·
6 min read
Pharm Country

National MS Society Commits $12 Million to 40 New Research Projects to Stop Multiple Sclerosis, Restore Function and End MS Forever

A cutting-edge treatment for fatigue, strategies to repair myelin, and MS risk factor candidates are among the new leads being explored

October 3, 2018
·
2 min read
Business

InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up

Research agreement for biofermentation development and scale-up processes for cannabinoid biosynthesis in E.coli.

October 3, 2018
·
4 min read
Drug Development

Risdiplam Demonstrates Preliminary Evidence of Clinical Benefit in Type 1, 2, & 3 Spinal Muscular Atrophy Patients

Babies from FIREFISH Part 1 study showed increased survival & gains in developmental milestones

October 3, 2018
·
9 min read
Biotech Bay

Genentech Announces New Data for Risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress

Preliminary findings from Part 1 of the FIREFISH study show that infants with Type 1 SMA are meeting developmental milestones, including sitting without support

October 3, 2018
·
7 min read